Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kadriye Bir Yücel, Atiye Cenay Karabörk Kilic, Osman Sütcüoglu, Ozan Yazıcı, Koray Kilic, Gözde Savaş, Aytug Uner, Nazan Günel, Ahmet Özet & Nuriye Özdemir. (2023) Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy. Journal of Chemotherapy 0:0, pages 1-9.
Read now
Read now
Yulei Lu, Shengming Wu, Bangde Xiang, Lequn Li & Youzhi Lin. (2020) Curcumin Attenuates Oxaliplatin-Induced Liver Injury and Oxidative Stress by Activating the Nrf2 Pathway. Drug Design, Development and Therapy 14, pages 73-85.
Read now
Read now
Articles from other publishers (16)
Norihiro Ishii, Norifumi Harimoto, Takaomi Seki, Ryo Muranushi, Kei Hagiwara, Mariko Tsukagoshi, Akira Watanabe, Yuka Yoshida, Kenichiro Araki & Ken Shirabe. (2023) Autotaxin is a novel surrogate marker for oxaliplatin‐related sinusoidal obstruction syndrome in patients with colorectal liver metastasis. Hepatology Research.
Crossref
Crossref
Ji Eon Park, Chi-Hoon AhnHyo-Jung LeeDeok Yong SimSu Yeon ParkBonglee KimBum Sang ShimDae Young Lee & Sung-Hoon Kim. (2023) Antioxidant-Based Preventive Effect of Phytochemicals on Anticancer Drug-Induced Hepatotoxicity. Antioxidants & Redox Signaling.
Crossref
Crossref
Rei Toda, Satoru Seo, Yusuke Uemoto, Koshiro Morino, Hiroto Nishino, Naohiko Nakamura, Masayuki Okuno, Kohta Iguchi, Motohiko Sato, Kojiro Nakamura, Kojiro Taura, Shunsaku Nakagawa, Takayuki Nakagawa, Tatsuaki Tsuruyama, Toshiaki Manabe, Hiroaki Kawaguchi, Keiko Iwaisako, Masaya Ikegawa, Shinji Uemoto & Etsuro Hatano. (2022) Clinically relevant model of oxaliplatin‐induced sinusoidal obstruction syndrome. Hepatology Research 53:2, pages 145-159.
Crossref
Crossref
Rika Saito, Yasuyuki Kawamoto, Mutsumi Nishida, Takahito Iwai, Yasuka Kikuchi, Isao Yokota, Ryo Takagi, Takahiro Yamamura, Ken Ito, Kazuaki Harada, Satoshi Yuki, Yoshito Komatsu & Naoya Sakamoto. (2022) Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome. International Journal of Clinical Oncology 27:11, pages 1780-1790.
Crossref
Crossref
Chen Zhu, Xinwei Cheng, Ping Gao, Qianyan Gao, Ximin Wang, Dong Liu, Xiuhua Ren & Chengliang Zhang. (2022) Model establishment and microarray analysis of mice with oxaliplatin‑induced hepatic sinusoidal obstruction syndrome. Molecular Medicine Reports 26:5.
Crossref
Crossref
Shunsuke Nagahama, Masayuki Ueno, Kazuhiro Terada, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto & Motowo Mizuno. (2022) Oxaliplatin-induced sinusoidal obstructive syndrome: A comparative study on clinical and pathological findingsオキサリプラチンによる肝類洞閉塞症候群―臨床像と病理像の対比―. Kanzo 63:8, pages 372-380.
Crossref
Crossref
Youssef Bouferraa, Yolla Haibe, Elio Jabra, Maya Charafeddine, Malek Kreidieh, Randa Raad, Sally Temraz, Deborah Mukherji, Firas Ershaid, Nadim Muallem, Walid Faraj, Mohamad Khalife, Rania A. Eid & Ali Shamseddine. (2022) Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity. Journal of Clinical and Experimental Hepatology 12:2, pages 448-453.
Crossref
Crossref
Ahmaduddin Khan & Niroj Kumar Sahu. (2021)
Hydrazone conjugated and DOX loaded PEGylated-Fe
3
O
4
mesoporous magnetic nanoclusters (MNCs): hyperthermia and
in vitro
chemotherapy
. New Journal of Chemistry 45:46, pages 21646-21656.
Crossref
Crossref
Chen Zhu, Xiuhua Ren, Dong Liu & Chengliang Zhang. (2021) Oxaliplatin-induced hepatic sinusoidal obstruction syndrome. Toxicology 460, pages 152882.
Crossref
Crossref
Roser Velasco, Montserrat Alemany, Macarena Villagrán & Andreas A. Argyriou. (2021) Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity. Journal of Personalized Medicine 11:7, pages 669.
Crossref
Crossref
Ji Su Kim, Jeong Youp Park, Munseok Choi, Dong Jin Joo, Ho Kyoung Hwang, Woo Jung Lee & Chang Moo Kang. (2021) Pancreaticoduodenectomy with combined hepatic artery and portal vein resection after laparoscopic division of pancreaticosplenic ligament due to FOLFIRINOX-induced hepatic toxicity related secondary hypersplenism. Annals of Hepato-Biliary-Pancreatic Surgery 25:2, pages 307-312.
Crossref
Crossref
Daniel L. Hertz, Cindy Tofthagen & Sara Faithfull. 2021. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy
19
51
.
Ryo Ohta, Takeshi Yamada, Keisuke Hara, Takuma Iwai, Kohji Tanakaya, Keiichiro Ishibashi, Kazuhiko Yoshimatsu, Chihiro Kosugi, Masahiro Tsubaki, Hideo Nakajima, Masatoshi Oya, Hiroshi Yoshida, Keiji Koda & Hideyuki Ishida. (2020) Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan. International Journal of Clinical Oncology 25:12, pages 2075-2082.
Crossref
Crossref
Justin G. Lees, Daniel White, Brooke A. Keating, Mallory E. Barkl-Luke, Preet G. S. Makker, David Goldstein & Gila Moalem-Taylor. (2020) Oxaliplatin-induced haematological toxicity and splenomegaly in mice. PLOS ONE 15:9, pages e0238164.
Crossref
Crossref
Hejing Bao, Gang Li, Yinhua Fang, Qin Lai, Hehong Bao, Yu Zheng & Yanjun Hu. (2020) Immunosuppression and cardiovascular dysfunction in patients with severe versus mild coronavirus disease 2019: a case series. Clinical & Translational Immunology 9:10.
Crossref
Crossref
Daniel A. Smith, Bhanusupriya Somarouthu & Nikhil H. Ramaiya. (2019) An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know. Abdominal Radiology 44:6, pages 2182-2195.
Crossref
Crossref